Burning Rock Biotech Limited (BNR) Earnings Call Analysis
NASDAQ · Healthcare · Diagnostics & Research
Earnings Reports
-
Burning Rock (BNR) Q1 2024: In-Hospital Revenue Mix Surpasses 50%, Marking Strategic Inflection
May 29, 2024
-
Burning Rock (BNR) Q4 2023: Pharma Segment Grows 59% as Cost Cuts Drive Path to Profitability
March 29, 2024
-
Burning Rock (BNR) Q3 2023: In-Hospital Revenue Rises 10% as Central Lab Contracts 41%, Accelerating Strategic Channel Shift
November 30, 2023